PROTECTA XT VR
Report
- Report Number
- 6000094-2011-01297
- Event Type
- Injury
- Date Received
- August 10, 2011
- Date of Event
- July 19, 2011
- Manufacturer
- MEDTRONIC S.A.
- Product Code
- NIK
- PMA / PMN Number
- ASKU
- Removal / Correction Number
- ASKU
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. EVALUATION SUMMARY: (B)(4) THE DEVICE WAS RETURNED TO THE MANUFACTURER AND ANALYSIS REVEALED THERE WAS GROMMET DAMAGE. THE ACTUAL DEVICE WAS RECEIVED FOR EVALUATION. WE DID RECEIVE PERFORMANCE DATA COLLECTED FROM THE DEVICE AND HAVE ANALYZED THE DATA AND NO ANOMALIES WERE FOUND.
THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. EVALUATION SUMMARY: (B)(4) THE DEVICE WAS RETURNED, ANALYZED AND NO ANOMALIES WERE FOUND. THE ACTUAL DEVICE WAS RECEIVED FOR EVALUATION. WE DID RECEIVE PERFORMANCE DATA COLLECTED FROM THE DEVICE AND HAVE ANALYZED THE DATA AND NO ANOMALIES WERE FOUND.
THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS.
THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. ANALYSIS OF THE DEVICE IS IN PROCESS; THE RESULTS WILL BE FORWARDED WHEN AVAILABLE.
IT WAS REPORTED THAT DURING DEVICE IMPLANT, THE DEFIBRILLATION IMPEDANCE WAS GREATER THAN 200 OHMS. THE PIN WAS RE-INSERTED ON SEVERAL OCCASIONS WITH THE SAME MEASUREMENT. WHEN TESTING THE DEVICE BY INDUCING VENTRICULAR FIBRILLATION, THE T-WAVE SHOCK WAS UNABLE TO INDUCE. THE PATIENT REQUIRED EXTERNAL DEFIBRILLATION AND IT IS REPORTED THAT ALTHOUGH THE DEVICE WAS PROGRAMMED TO GIVEN 25 JOULES ON THERAPY ONE AND 35 JOULES ON THERAPY TWO, THE DELIVERED ENERGY WAS 0.8 JOULES AND 0.9 JOULES RESPECTIVELY. THE VENTRICULAR FIBRILLATION INDUCTION WAS REPEATED AND TESTED AND EXTERNAL DEFIBRILLATION WAS REQUIRED A SECOND TIME. THE DELIVERED ENERGY WAS REPORTED AS 0.5 JOULES AND 0.9 JOULES. THE DEVICE WAS REMOVED AND REPLACED AND THE LEAD WAS CAPPED AND REPLACED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PROTECTA XT VR | IMPLANTABLE PACEMAKER/CARDIO/DEFIB | NIK | MEDTRONIC S.A. | D354VRG | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 7 YR | Hospitalization| L| R | 4968 IMPLANTABLE PACING LEAD| 4968 IMPLANTABLE PACING LEAD| 4968 IMPLANTABLE PACING LEAD| 4968 IMPLANTABLE PACING LEAD |